FXYD3-TARM1 Fusion FISH Probe
The FXYD3-TARM1 Fusion FISH Probe is used to confirm a fusion of the FXYD3 and TARM1 genes. The fusion of the FXYD3 and TARM1 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FXYD3-TARM1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FXYD3-TARM1-20-AQAQ | 20 (40 μL) | 200 μL |
|
FXYD3 Gene Summary
This gene belongs to a small family of FXYD-domain containing regulators of Na+/K+ ATPases which share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD, and containing 7 invariant and 6 highly conserved amino acids. This gene encodes a cell membrane protein that may regulate the function of ion-pumps and ion-channels. This gene may also play a role in tumor progression. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2008]
Gene Name: FXYD Domain Containing Ion Transport Regulator 3
Chromosome: CHR19: 35606731 -35615228
Locus: 19q13.12
TARM1 Gene Summary
The T-cell-interacting, Activating Receptor On Myeloid Cells 1 (TARM1) gene is located on chr19 :54573200-54584634 at 19q13.42.
Gene Name: T-cell-interacting, Activating Receptor On Myeloid Cells 1
Chromosome: CHR19: 54573200 -54584634
Locus: 19q13.42
Gene Diseases
The FXYD3 TARM1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|